BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8165627)

  • 1. HN-11500--a novel thromboxane A2 receptor antagonist with antithrombotic activity in humans at arterial blood flow conditions.
    Roald HE; Barstad RM; Engen A; Kierulf P; Skjørten F; Sakariassen KS
    Thromb Haemost; 1994 Jan; 71(1):103-9. PubMed ID: 8165627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel--a platelet inhibitor which inhibits thrombogenesis in non-anticoagulated human blood independently of the blood flow conditions.
    Roald HE; Barstad RM; Kierulf P; Skjørten F; Dickinson JP; Kieffer G; Sakariassen KS
    Thromb Haemost; 1994 May; 71(5):655-62. PubMed ID: 8091395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axial dependence of collagen-induced thrombus formation in flowing non-anticoagulated human blood. Anti-platelet drugs impair thrombus growth and increase platelet-collagen adhesion.
    Roald HE; Sakariassen KS
    Thromb Haemost; 1995 Jan; 73(1):126-31. PubMed ID: 7740484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood.
    Barstad RM; Kierulf P; Sakariassen KS
    Thromb Haemost; 1996 Apr; 75(4):685-92. PubMed ID: 8743200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new method for quantifying platelet deposition in flowing native blood in an ex vivo model of human thrombogenesis.
    Bossavy JP; Sakariassen KS; Barret A; Boneu B; Cadroy Y
    Thromb Haemost; 1998 Jan; 79(1):162-8. PubMed ID: 9459343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial interactions of platelets and plasma proteins in flowing non-anticoagulated human blood with the artificial surfaces Dacron and PTFE.
    Roald HE; Barstad RM; Bakken IJ; Roald B; Lyberg T; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):355-63. PubMed ID: 8075307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion.
    Roald HE; Orvim U; Bakken IJ; Barstad RM; Kierulf P; Sakariassen KS
    Arterioscler Thromb; 1994 Apr; 14(4):617-21. PubMed ID: 8148359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ; Weng D; Chesebro JH; Fuster V; Badimon L
    Thromb Haemost; 1994 Apr; 71(4):511-6. PubMed ID: 8052972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the oral anticoagulant phenprocoumon on blood coagulation and thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood: role of dose and shear rate.
    Inauen W; Bombeli T; Baumgartner HR; Haeberli A; Straub PW
    J Lab Clin Med; 1991 Sep; 118(3):280-8. PubMed ID: 1919300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upstream thrombus growth impairs downstream thrombogenesis in non-anticoagulated blood: effect of procoagulant artery subendothelium and non-procoagulant collagen.
    Sakariassen KS; Weiss HJ; Baumgartner HR
    Thromb Haemost; 1991 May; 65(5):596-600. PubMed ID: 1871722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR; Hubbell JA
    J Lab Clin Med; 1992 Jun; 119(6):690-7. PubMed ID: 1534345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antithrombotic effect of thromboxane receptor antagonist HN 11500 on thrombus formation in laser thrombosis model and platelet function tests.
    Krupiński K; Ferber H; Breddin HK; Bielawiec M
    Acta Haematol Pol; 1994; 25(3):235-42. PubMed ID: 7992596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow.
    Barstad RM; Orvim U; Hamers MJ; Tjønnfjord GE; Brosstad FR; Sakariassen KS
    Thromb Haemost; 1996 May; 75(5):827-32. PubMed ID: 8725731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-thrombin bound to extracellular endothelial matrix induces pronounced fibrin deposition and platelet thrombus growth in flowing non-anticoagulated human blood.
    Salatti JA; Fenton J; Anton P; Sakariassen KS
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):561-6. PubMed ID: 7841312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced thrombus formation in native blood of homozygous factor VII-deficient patients at high arterial wall shear rate.
    Barstad RM; Stormorken H; Orning L; Stephens RW; Petersen LB; Kierulf P; Sakariassen KS
    Blood; 1994 Nov; 84(10):3371-7. PubMed ID: 7949091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis.
    Orvim U; Barstad RM; Vlasuk GP; Sakariassen KS
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2188-94. PubMed ID: 7489241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions.
    Hamada M; Sugimoto M; Matsui H; Mizuno T; Shida Y; Doi M; Fukushima H; Nishio K; Yoshioka A; Shima M
    Thromb Haemost; 2011 Feb; 105(2):313-20. PubMed ID: 21136018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.